|
HS Code |
444766 |
| Iupac Name | Ethyl 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
| Molecular Formula | C23H20N4O6 |
| Molecular Weight | 448.43 g/mol |
| Appearance | Yellow solid |
| Solubility | Soluble in DMSO, slightly soluble in ethanol |
| Melting Point | 195-198°C |
| Purity | Typically ≥98% (HPLC) |
| Structural Formula | C(COC(=O)c1nn2CCCC(=O)c2c(n1)c3ccc(OC)cc3)c4ccc([N+](=O)[O-])cc4 |
| Smiles | CCOC(=O)c1nn2CCCC(=O)c2c(n1)c3ccc(OC)cc3c4ccc([N+](=O)[O-])cc4 |
| Storage Temperature | 2-8°C |
| Hazard Statements | May cause eye and skin irritation |
As an accredited 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, sealed 10g amber glass bottle with screw cap, labeled with chemical name, CAS number, hazard symbols, and storage instructions. |
| Container Loading (20′ FCL) | 20′ FCL contains securely packed drums of 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)...ethyl ester, ensuring safe bulk shipment. |
| Shipping | The chemical **4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester** is shipped in sealed, inert containers under ambient or temperature-controlled conditions, protected from light and moisture. All relevant hazardous material regulations and safety guidelines are strictly followed during packaging, labeling, and transit. |
| Storage | Store 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester in a tightly sealed container, protected from light, moisture, and air. Keep it at room temperature (15–25°C) in a well-ventilated, dry chemical storage area. Avoid strong acids, bases, and oxidizing agents. Label containers appropriately and keep away from incompatible substances. |
| Shelf Life | Shelf life: Store tightly sealed at 2–8°C, protected from light and moisture; stable for at least 2 years under recommended conditions. |
|
Purity 98%: 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este with purity 98% is used in pharmaceutical intermediate synthesis, where it ensures high yield and minimal impurity levels. Melting Point 192–195°C: 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este with a melting point of 192–195°C is used in medicinal chemistry research, where consistent thermal stability facilitates reproducible crystallization. Molecular Weight 442.41 g/mol: 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este with a molecular weight of 442.41 g/mol is used in structure-activity relationship studies, where precise molecular characterization enables targeted drug design. Stability Temperature up to 120°C: 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este stable up to 120°C is used in advanced organic synthesis, where robust thermal stability prevents decomposition during reactions. Particle Size <10 µm: 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este with particle size <10 µm is used in formulation development, where fine dispersion enhances dissolution rate and bioavailability. HPLC Assay ≥99%: 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este with HPLC assay ≥99% is used in analytical quality control, where it enables accurate and reliable quantification in sample matrices. Solubility in DMSO 50 mg/mL: 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este with solubility in DMSO at 50 mg/mL is used in biochemical assays, where high solubility allows preparation of concentrated stock solutions. LogP 3.2: 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este with LogP 3.2 is used in pharmacokinetic profiling, where balanced hydrophilicity and lipophilicity support optimal membrane permeability. |
Competitive 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
We have poured years of bench-scale innovation and full-scale production work into developing 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester. This molecule embodies a specific purpose in the world of advanced intermediate chemicals: it brings a precisely tailored scaffold to medicinal research, agrochemical leads, and new material synthesis. The design behind its structure—carrying both methoxy and nitro phenyl rings along with the versatile pyrazolo-pyridine core—opens up chemical behaviors not accessible from other, less intricate heterocyclic esters.
Building this compound in our reactors taught us a lot about how small structural tweaks impact larger study outcomes. By combining a 4-methoxyphenyl group at position 1 and a 4-nitrophenyl at position 6, the compound demonstrates distinct polar and electronic features. Such dual functionalization can lead to improved receptor affinity or higher biological screening hit rates. Unlike simple pyrazole esters or undiversified pyridine precursors, this product shows differentiated selectivity in screening assays and processes like high-throughput pharmaceutical candidate selection.
Scaling up a fused heterocycle with both electron-donating and electron-withdrawing substituents brought concrete challenges. Maintaining purity above 99% required careful solvent selection and real-time monitoring of side reactions, especially during the introduction of the nitro-substituted phenyl ring. The ethyl ester function extends synthetic flexibility: downstream users can hydrolyze it for acid analogues or use it for further coupling without worrying about base-sensitive routes. Many suppliers offer simple pyrazole esters with little customization. Here, our direct control from raw material sourcing to crystallization means we troubleshoot and optimize for the rigors of R&D projects, not generic supply chains.
Working closely with medicinal chemistry teams, we notice they value how our product’s complex pattern of substitution enables a direct jumpstart on lead optimization, particularly in kinase inhibitor programs and anti-infective compound libraries. Its structural features attract attention for receptor modeling, as they mimic motifs in several FDA-approved drugs. Academic teams report that the ester group allows robust conjugation, so the compound serves not just as an endpoint, but as a versatile building block. Researchers from crop science backgrounds leverage the same core structure for generating analogs with selective activity against insect or fungal targets. Unlike simpler heterocycles lacking dual aryl substitution, our product’s profile widens the research pathway.
From raw material inspection through final packaging, we prioritize consistency and transparency. Our reactors operate under validated conditions, resulting in reproducible yield and color. Users report minimal byproduct interference during purification steps—a critical factor for those seeking straightforward NMR and LCMS analysis. We control particle size through solvent selection, aiding dispersion and limiting dust during transfer. No batch ships without passing GC and HPLC confirmation, ensuring that each drum or jar mirrors the next in composition and performance. This hands-on control suits labs frustrated by batch-to-batch flaws found in brokered specialty chemicals.
A lot of commercial material on the market draws from generic catalog syntheses. We take a different view. For example, we never outsource core steps for this compound; synthesis, purification, and quality tests happen in-house. By managing each operation, we build direct knowledge into our workflow, allowing us to adapt process parameters when new data surfaces from customer labs or our own analytics team. The result: steadier timelines, deeper technical support, and a direct link between the chemistry we run and the hands using these products worldwide.
A key question our clients ask goes beyond the CAS number. Researchers want to know: can this intermediate handle further derivatization under basic or acidic conditions? Through our own synthetic campaigns, we learned that the ethyl ester functionality remains robust through a range of coupling and hydrolysis reactions, with yields holding strong even at larger scales. Some projects required custom particle sizes or unique morphologies, and our team delivered by tweaking crystallization kinetics and filtration protocols. Time after time, we see that our ownership of both process chemistry and post-synthetic handling makes practical, project-specific problem-solving possible.
Drug discovery today moves quickly; scaffold modification cycles demand reliability. This ester stands out because its specific fusion of pyrazolo and pyridine rings, plus dual aryl substituents, offers medicinal chemists a more advanced starting point. Structure-based drug design groups appreciate its molecular rigidity and the tunable electronics provided by the methoxy and nitro groups. We’ve watched how teams reduce their total synthesis steps when they start with our intermediate, compared with more basic pyrazole esters that require late-stage arylation. The structure we produce supports direct analog expansion, SAR campaigns, and combinatorial library diversification.
Beyond the science, paperwork and regulatory filings surround every new chemical entity. Having run formal analytical method validation on this product, we know the peaks and pitfalls of demonstrating purity, residual solvents, and potential genotoxic impurities. Our quality team built documentation for both internal use and client regulatory packets, so our partners save time preparing for their own filings. We keep solvent profiles tight and avoid common allergenic solvents; all batches receive barcode-tagged, traceable reports. These steps ease headaches for quality assurance officers and compliance teams in pharma and crop chemical development firms.
We work alongside customers who need variations—sometimes it’s a different ester chain, sometimes it’s about scaling up unique analogues for program-specific studies. Because we own the full manufacturing route, changes happen quickly and efficiently, without weeks lost in contract waiting periods. Labs looking to swap ethyl for methyl esters, or seeking deuterated versions for tracer studies, can speak directly to our synthesis managers for workable plans. Unlike resellers dependent on outside suppliers, we act on feedback, providing gram-to-kilo lots to support emerging research needs without minimum order headaches.
Knowledge spills both ways in this business. Regular calls with academic and industrial researchers enable us to tweak our procedures, solve on-the-fly isolation issues, and ensure every delivery truly meets the expectations of cutting-edge users. Last year, a team exploring photo-switchable bioactivity requested a series of closely related pyrazolo[3,4-c]pyridines, with various electronic groupings. Collaborating on such projects taught us to fine-tune regioselectivity and streamline purification across a wider product set. In these situations, we share our findings—like NMR shifts linked to specific substitutions—helping colleagues advance their programs while sharpening our own process control.
Beyond the world of pharmaceuticals and agrochemicals, demand for heterocyclic scaffolds grows in advanced materials. Our customers experiment with electronic sensors, OLEDs, and functional coatings, placing high value on well-characterized building blocks that deliver reproducible performance. The electron-rich and electron-deficient aryl substituents in our ester place it in a unique spot for tuning charge mobility and optical properties. Research groups fabricating field-effect transistors or non-linear optics templates find that less-substituted pyrazolo[3,4-c]pyridines simply cannot match the range enabled by this compound. Our track record supplying both research and pre-production lots gives these innovators confidence as they scale up for pilot trials.
Achieving high-purity, complex intermediates at commercial scale forces us to grapple with both chemistry and logistics. We learned that storing and shipping this ester calls for tightly controlled humidity and light exposure to maintain shelf life, especially compared to more stable, less functionalized analogues. Temperature fluctuations during transit can trigger minor color changes, so our logistics focus on sealed containers, cold-chain options, and clear labeling. Occasionally, packaging specs adapt based on end-user demonstration of a specific bottleneck—like static electricity or need for inert atmosphere handling. We’ve seen time lost on distant projects simply because earlier suppliers skipped these details; responsiveness in packing builds trust.
An overlooked topic in fine chemical supply: waste management. Through iterative process improvements, we reduced byproduct formation on multiple steps and designed workups that cut solvent use by nearly 30 percent per kilo compared to earlier procedures. Feeds from our manufacturing lines commonly meet the low-waste standards required at major pharmaceutical firms, so compliance documentation follows each lot. By experimenting with templated crystallization and solvent recovery, we helped further downstream users by lowering VOC levels and simplifying disposal requirements. Unlike catalog vendors who favor speed, our strategy factors in the end-to-end environmental impact, not stopping at the factory gate.
In chemical manufacturing, real information builds long-term relationships. We disclose all core data on melting point ranges, solvent residues, and recent spectral characterizations to clients upon each batch shipment, not just on request. Having handled this compound across numerous campaigns, our lab teams noticed subtle lot-to-lot differences that occasionally spike reactivity or color—details missed by occasional handlers. We keep both supplier and internal reference lots for direct comparison—supporting thorough troubleshooting if inconsistencies arise downstream. Such openness leads to feedback loops that improve outcomes for all related research programs.
Every few quarters, new literature emerges describing different substitution patterns on the pyrazolo[3,4-c]pyridine ring. Our hands-on experience synthesizing this ester, coupled with feedback from diverse clients, prepares us to tackle next-generation analogues. Whether clients request new photographic markers, unusual protecting groups, or alternative linkage positions, our direct investment in process research pays off. Rather than relying on catalog expansion by chance, we regularly update synthetic offerings based on real-world activity in therapeutic and crop science pipelines, aiming to keep our fellow chemists moving forward faster.
With global upheavals in logistics and material costs, manufacturers face mounting delivery uncertainty. Our approach centers on keeping core raw materials in stock, tightly managing vendor certification, and running continuous rather than campaign-based manufacturing. These efforts allow us to fill both short-notice rush orders and sustained multi-kilo programs without extended downtime. Thanks to in-house process control, we avoid price surges or extended stockouts typical of brokered fine chemicals. Labs with time-sensitive projects find our rapid lead times and open technical support critical, particularly for projects under regulatory or funding deadlines.
As chemical regulations shift—region by region and according to performance hazard findings—we stay alert by tracking global guidelines and participating in relevant sector networks. Over the past year, expanded pre-registration and transport compliance requirements led us to upgrade documentation and repackaging workflows to avoid customs delays and provide clear hazard labeling. This proactive stance helps partner labs in biotech, academia, and materials R&D stay audit-ready as standards evolve.
In the search for new medicines, materials, and crop protection agents, the need for synthetically versatile, well-characterized building blocks grows each year. We have watched this compound’s pattern of substitution enable faster pivoting to new analogs during hit expansion. Its electronic balance opens more doors in molecular docking and combinatorial synthesis. The reliable quality, consistent supply, and technical backing we deliver matter more as research schedules shorten and complexity rises. These are benefits single-use suppliers and resellers cannot match, given their separation from real production and process outcomes.
Feedback from users—on process noise, trace impurity levels, particle size variation, or downstream reactivity—forms the backbone of our improvement cycles. Our commitment to ongoing training, equipment upgrades, and method validation means each batch reflects our best available knowledge, not just a frozen protocol. By embracing day-to-day production challenges and remaining open to collaboration, we’ve advanced both the quality and relevance of our 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester, striving to keep our products an engine for discovery and application in the world’s top labs.